Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway

被引:0
|
作者
Rock, KL [1 ]
Clark, K [1 ]
机构
[1] HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA
来源
JOURNAL OF IMMUNOLOGY | 1996年 / 156卷 / 10期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
By conjugation of proteins to beads, Ags can be selectively targeted into the MHC class I pathway of phagocytes in vivo and can stimulate CTL responses. Because phagocytes also present particulate Ag on MHC class II molecules, we examined whether these Ags stimulated concomitant CD4 T cell immunity. Although the priming of CD4 T cells with soluble OVA required adjuvants, particulate Ag was stimulatory when injected in saline. We next examined whether CD4 T tell responses played a role in the generation of CTL to particulate Ag. At low concentrations of Ag, OVA primed CTLs in wild-type mice but not in MHC class II-deficient animals, indicating that MHC class II presentation of Ag was essential for CTL generation. These data both support a model where CD4 T cells collaborate with CTLs as part of a three-cell interaction and identify a phagocyte as the third cell in this reaction. Interestingly, injection of higher concentrations of the same Ag primed equivalent CTL responses in both wild-type and MHC class II-deficient mice. These results indicate that a key variable in determining whether CTL generation is helper cell dependent or independent is the dose of immunogen. This may explain in part why CTL responses to abundant Ags, such as viruses, tend to be helper independent, while responses to less abundant Ags, such as minor histocompatibility Ags, require T helper cells. In addition, these results also point to the potential of using particulate Ags to prime or boost responses in settings with CD4 immunodeficiency.
引用
收藏
页码:3721 / 3726
页数:6
相关论文
共 50 条
  • [41] Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes
    Potter, NS
    Harding, CV
    JOURNAL OF IMMUNOLOGY, 2001, 167 (05): : 2538 - 2546
  • [42] Genetic engineering of antigen presentation of MHC class-II restricted antigens
    Wang, RF
    Wang, X
    Atwood, A
    Rosenberg, SA
    FASEB JOURNAL, 1999, 13 (04): : A275 - A275
  • [43] Viral inhibition of MHC class II antigen presentation
    Hegde, NR
    Chevalier, MS
    Johnson, DC
    TRENDS IN IMMUNOLOGY, 2003, 24 (05) : 278 - 285
  • [44] Influence of Salmonella on MHC class II antigen presentation
    Jackson, N.
    Kang, Y. H.
    Lapaque, N.
    Janssen, H.
    Trowsdale, J.
    Kelly, A. P.
    IMMUNOLOGY, 2012, 137 : 478 - 478
  • [45] Proteases involved in MHC class II antigen presentation
    Villadangos, JA
    Bryant, RAR
    Deussing, J
    Driessen, C
    Lennon-Duménil, AM
    Riese, RJ
    Roth, W
    Saftig, P
    Shi, GP
    Chapman, HA
    Peters, C
    Ploegh, HL
    IMMUNOLOGICAL REVIEWS, 1999, 172 : 109 - 120
  • [46] Fc receptors for IgG and antigen presentation on MHC class I and class II molecules
    Amigorena, S
    Bonnerot, C
    SEMINARS IN IMMUNOLOGY, 1999, 11 (06) : 385 - 390
  • [47] A role for membrane rafts in antigen presentation by MHC class II molecules
    Anderson, HA
    Roche, PA
    FASEB JOURNAL, 2000, 14 (06): : A1195 - A1195
  • [48] Routes to manipulate MHC class II antigen presentation
    van den Hoorn, Tineke
    Paul, Petra
    Jongsma, Marlieke L. M.
    Neefjes, Jacques
    CURRENT OPINION IN IMMUNOLOGY, 2011, 23 (01) : 88 - 95
  • [49] Chaperoning antigen presentation by MHC class II molecules and their role in oncogenesis
    Marsman, M
    Jordens, I
    Griekspoor, A
    Neefjes, J
    ADVANCES IN CANCER RESEARCH, VOL 93, 2005, 93 : 129 - 158
  • [50] Class I MHC molecules: assembly and antigen presentation
    Solheim, JC
    IMMUNOLOGICAL REVIEWS, 1999, 172 : 11 - 19